Plamotamab (XmAb®13676) for Ibrutinib- refractory CXCR4-mutated extramedullary Waldenström macroglobulinemia. - Parrondo, Ricardo D.; Paulus, Aneel; Alegria, Victoria; Liebowitz, David; Johnson, Chelsea; Clynes, Raphael; Roy, Vivek; Menke, David M.; Jiang, Liuyan; Chanan-Khan, Asher A.; Ailawadhi, Sikander (Leukemia & Lymphoma, 2022)